Material
Cerebroprotein hydrolysate
Cognitive research
Cerebrolysin60 MG
Prepared for controlled research into neuro-signaling and cellular response models.
MaterialCerebroprotein hydrolysate
SpecificationPurity 99%+
Research contextComplex neuropeptide preparation research.
Veyvanta / profile
Compound profile
* Vial labels may use shortened names to keep the label legible. The full material and composition are stated in this profile.
Composition
Process-defined mixture of low-molecular-weight peptides and free amino acids.
Research context
Complex neuropeptide preparation research.
Identity note
The lyophilized material is identified as cerebroprotein hydrolysate. It is a complex mixture, not a single molecule, and is not represented as interchangeable with any branded drug product.
Research interest
Why it draws attention
This complex peptide preparation is studied for neuroplasticity, neuronal recovery, and functional-rehabilitation pathways rather than as a single defined molecule.
Signals researchers are following
- 01
Neurorecovery and functional rehabilitation after brain injury
- 02
Complex peptide-mixture effects on neuronal survival and plasticity
Evidence levelMixed human and preclinical evidence
Published evidence / research profile
What the published research shows
A source-led view of the findings reported to date, the maturity of the evidence, and the limits that matter when interpreting it.
Evidence levelMixed human and preclinical evidence
Common research directions
- Neurorecovery and functional rehabilitation after brain injury
- Complex peptide-mixture effects on neuronal survival and plasticity
Reported findings
Some randomized stroke studies reported improved functional measures, while authors also called for larger confirmatory trials. The broader literature is heterogeneous across indication, formulation, study size, and outcome.
How to read the evidence
Published clinical studies evaluate defined branded liquid formulations. A lyophilized cerebroprotein hydrolysate is a process-defined mixture and cannot be assumed to be compositionally or clinically interchangeable.
Selected references
Cerebrolysin With Speech Therapy After Ischemic Stroke: ESCASStroke (2025)View sourceCerebrolysin After Mechanical Thrombectomy: Prospective Follow-UpTransl Stroke Res (2025)View sourceCerebrolysin and Recovery After Stroke (CARS)Stroke (2016)View sourceCerebrolysin in Early Recovery After Ischemic StrokeJ Med Life (2017)View source
This summary describes published research on the named material or its components. It does not establish safety, efficacy, equivalence, or suitability of this Veyvanta research product for human use.
Lab math
Reconstitution & measurement calculator
Convert a declared vial amount and diluent volume into nominal concentration, liquid volume, and the equivalent position on a U-100 scale.
Research product
Research productCerebrolysin / 60 MG
Calculation basisCerebrolysin
Calculated measurement
Enter a positive diluent volume and target amount to calculate.
A calculation, not a protocol
This tool performs unit conversion only. It does not recommend an amount, frequency, route, diluent, handling method, or human use. Results assume ideal mixing and a U-100 scale of 100 units per mL; validated laboratory procedures and material-specific compatibility take priority.
Vial verification
Verify this vial
This is the evergreen product profile. Enter the code from a physical vial to display its specific record.
Verify this vial
Vial verification QR
This QR code opens the current product profile with its associated vial record.
Cognitive research
